Skip to content

Clinical trials

Immunoglobulin Light-chain Amyloidosis trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoglobulin Light-chain Amyloidosis Country / region: Italy Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20021
20052
20112
20122
20152
20161
20171
20191
20204
20213
20222
20233
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting7
Terminated6
Active, not recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fondazione IRCCS Policlinico San Matteo di Pavia12
European Organisation for Research and Treatment of Cancer - EORTC4
European Myeloma Network B.V.3
Prothena Biosciences Ltd.3
Alexion Pharmaceuticals, Inc.2
Fred Hutchinson Cancer Center2
K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.1
Leiden University Medical Center1
Millennium Pharmaceuticals, Inc.1
National Cancer Institute (NCI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoglobulin Light-chain Amyloidosis32
Multiple Myeloma10
Amyloidosis6
Burkitt Lymphoma6
Hodgkin Disease6
Immunoblastic Lymphadenopathy6
Intraocular Lymphoma6
Leukemia, Biphenotypic, Acute6
Leukemia, Hairy Cell6
Leukemia, Large Granular Lymphocytic6

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.